<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><submitter>Yao Y</submitter><funding>the Fundamental Research Funds for the Central Universities</funding><funding>CAMS Innovation Fund for Medical Sciences</funding><funding>National Natural Science Foundation of China</funding><funding>Chengdu University of Traditional Chinese Medicine</funding><funding>National medical and health science technology strategic platform and system construction project</funding><funding>Non-profit Central Research Institute Fund of Chinese Academy of Medical Sciences</funding><pubmed_abstract>Despite considerable variation in disease manifestations observed among coronavirus disease 2019 (COVID-19) patients infected with severe acute respiratory syndrome coronavirus 2, the risk factors predicting disease severity remain elusive. Recent studies suggest that peripheral blood cells play a pivotal role in COVID-19 pathogenesis. Here, we applied two-sample Mendelian randomization (MR) analyses to evaluate the potential causal contributions of blood cell indices variation to COVID-19 severity, using single-nucleotide polymorphisms (SNPs) as instrumental variables for 17 indices from the UK Biobank and INTERVAL genome-wide association studies (N = 173 480). Data on the associations between the SNPs and very severe respiratory confirmed COVID-19 were obtained from the COVID-19 host gen</pubmed_abstract><journal>Journal of medical virology</journal><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC9538306</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Genetic predisposition to blood cell indices in relation to severe COVID-19.</pubmed_title><pmcid>PMC9538306</pmcid><funding_grant_id>2021‐I2M‐1‐041</funding_grant_id><funding_grant_id>No.2022‐I2M‐2‐003</funding_grant_id><funding_grant_id>No.2022-I2M-2-003</funding_grant_id><funding_grant_id>2021YFA1102300</funding_grant_id><funding_grant_id>2021-RC310-015</funding_grant_id><funding_grant_id>2021-I2M-1-041</funding_grant_id><pubmed_authors>Zhang F</pubmed_authors><pubmed_authors>Liu J</pubmed_authors><pubmed_authors>Rao S</pubmed_authors><pubmed_authors>Yao Y</pubmed_authors><pubmed_authors>Wang D</pubmed_authors><pubmed_authors>Jiang C</pubmed_authors><pubmed_authors>Song H</pubmed_authors><pubmed_authors>Feng Q</pubmed_authors></additional><is_claimable>false</is_claimable><name>Genetic predisposition to blood cell indices in relation to severe COVID-19.</name><description>Despite considerable variation in disease manifestations observed among coronavirus disease 2019 (COVID-19) patients infected with severe acute respiratory syndrome coronavirus 2, the risk factors predicting disease severity remain elusive. Recent studies suggest that peripheral blood cells play a pivotal role in COVID-19 pathogenesis. Here, we applied two-sample Mendelian randomization (MR) analyses to evaluate the potential causal contributions of blood cell indices variation to COVID-19 severity, using single-nucleotide polymorphisms (SNPs) as instrumental variables for 17 indices from the UK Biobank and INTERVAL genome-wide association studies (N = 173 480). Data on the associations between the SNPs and very severe respiratory confirmed COVID-19 were obtained from the COVID-19 host gen</description><dates><release>2022-01-01T00:00:00Z</release><publication>2022 Aug</publication><modification>2025-04-04T23:20:52.367Z</modification><creation>2025-04-04T23:20:52.367Z</creation></dates><accession>S-EPMC9538306</accession><cross_references><pubmed>36039015</pubmed><doi>10.1002/jmv.28104</doi></cross_references></HashMap>